chitosan has been researched along with as 1411 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardestani, MS; Taki, S | 1 |
| Hu, X; Jeevithan, E; Mariadoss, AVA; Saravanakumar, K; Sathiyaseelan, A; Shin, S; Wang, MH | 1 |
| Che, C; Gao, R; Gong, Z; Liu, B; Liu, J; Si, M; Yang, G; Yang, W | 1 |
| Abnous, K; Bahrami, AR; Danesh, NM; Khatami, F; Matin, MM; Taghdisi, SM | 1 |
| Abnous, K; Alibolandi, M; Khademi, Z; Ramezani, M; Salmasi, Z; Taghdisi, SM; Zirak, MR | 1 |
5 other study(ies) available for chitosan and as 1411
| Article | Year |
|---|---|
Novel nanosized AS1411-chitosan-BODIPY conjugate for molecular fluorescent imaging.
Topics: Aptamers, Nucleotide; Boron Compounds; Cell Line, Tumor; Cell Proliferation; Chitosan; Endocytosis; Fluorescence; Fluorescent Dyes; HEK293 Cells; Humans; Microscopy, Atomic Force; Molecular Imaging; Nanoconjugates; Nanoparticles; Oligodeoxyribonucleotides; Particle Size; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Static Electricity | 2019 |
Dual stimuli-responsive release of aptamer AS1411 decorated erlotinib loaded chitosan nanoparticles for non-small-cell lung carcinoma therapy.
Topics: A549 Cells; Animals; Apoptosis; Aptamers, Nucleotide; Carcinoma, Non-Small-Cell Lung; Cell Survival; Chitosan; Drug Carriers; Drug Liberation; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Nanoparticles; NIH 3T3 Cells; Oligodeoxyribonucleotides; Reactive Oxygen Species; Signal Transduction | 2020 |
A Targeted Nano Drug Delivery System of AS1411 Functionalized Graphene Oxide Based Composites.
Topics: Antineoplastic Agents; Aptamers, Nucleotide; Chitin; Chitosan; Doxorubicin; Drug Carriers; Drug Liberation; Graphite; HeLa Cells; Humans; Immobilized Nucleic Acids; Nanocomposites; Oligodeoxyribonucleotides; Oligosaccharides; Polyglutamic Acid | 2021 |
Targeted delivery system using silica nanoparticles coated with chitosan and AS1411 for combination therapy of doxorubicin and antimiR-21.
Topics: Animals; Antagomirs; Antineoplastic Agents; Aptamers, Nucleotide; Cell Line, Tumor; Chitosan; CHO Cells; Cricetulus; Doxorubicin; Drug Carriers; Drug Liberation; Humans; Immobilized Nucleic Acids; Mice; MicroRNAs; Nanoparticles; Neoplasms; Oligodeoxyribonucleotides; Silicon Dioxide | 2021 |
A novel dual-targeting delivery system for specific delivery of CRISPR/Cas9 using hyaluronic acid, chitosan and AS1411.
Topics: Aptamers, Nucleotide; Chitosan; CRISPR-Cas Systems; Gene Transfer Techniques; HEK293 Cells; Humans; Hyaluronic Acid; Oligodeoxyribonucleotides | 2022 |